For Americans wary of the Johnson & Johnson COVID-19 vaccine as it returns to use after the investigation of a potentially deadly side effect, health experts have a message: The system worked.
A recommended hold on the vaccine was lifted on Friday by the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration after a 10-day review of rare and serious blood clots in some people who had received the shot.
The small risk of clots from the shot is far outweighed by its protection against the coronavirus, an advisory panel said. In the next six months, the shot could prevent some 1,435 COVID-19 deaths and 2,236 hospitalizations, compared with a projected 26 possible clot cases, according to a presentation by the CDC.
J&J s Second Act Creates New Challenge for Immunization Effort
bloombergquint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloombergquint.com Daily Mail and Mail on Sunday newspapers.
Some US states resume use of Johnson & Johnson COVID-19 vaccine
gnnliberia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gnnliberia.com Daily Mail and Mail on Sunday newspapers.
With OK from health experts, many states resume J&J vaccine use
U.S. health officials said Friday evening that they were lifting an 11-day pause on vaccinations using the J&J COVID-19 vaccine. Author: DAVID CRARY (AP National Writer) Published: 4:59 PM CDT April 24, 2021 Updated: 4:59 PM CDT April 24, 2021
NEW YORK With a green light from federal health officials, many states resumed use of the one-shot Johnson & Johnson coronavirus vaccine on Saturday. Among the venues where it was being deployed: the Indianapolis Motor Speedway.
Among the other states ordering or recommending a resumption, along with Indiana, were Arizona, Colorado, Connecticut, Louisiana, Maine, Massachusetts, Michigan, Missouri, Nevada, New York, Tennessee, Texas and Virginia.